Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern by BY KATHERINE J. WU AND KATIE THOMAS


The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.

Published: October 13, 2020 at 09:56PM

from NYT Health https://ift.tt/31lgGsv